Best’s Market Segment Report: AM Best Maintains Stable Outlook on Spain’s Life Insurance Segment
AMSTERDAM–(BUSINESS WIRE)–#insurance—AM Best has maintained its stable outlook on Spain’s life insurance segment. In its new Best’s Market... Read more.
Best’s Market Segment Report: AM Best Maintains Stable Outlook on Spain’s Non-Life Insurance Segment
AMSTERDAM–(BUSINESS WIRE)–#insurance—AM Best has maintained its stable outlook on Spain’s non-life insurance segment. In its new Best’s Market... Read more.
Faraday Future Celebrates Major Milestone in its Middle East “Third Pole” Strategy with its New Operations Facility Handover Ceremony in Ras Al Khaimah, UAE
The facility will support the production of both FF and potential Faraday X (FX) models, enabling the Company to serve diverse customer segments across the Gulf... Read more.
Curatis discloses Corticorelin as active substance of C-PTBE-01
Corticorelin Market Opportunity in Peritumoral Brain Edema (PTBE) expected to exceed USD 1 billion; Strengthens team with Dr. Kirsty Crame and Dr. Timm Trenktrog... Read more.
Vietnam Airlines and FPT Strengthen Comprehensive Strategic Partnership to Advance Digital Aviation
HANOI, Vietnam–(BUSINESS WIRE)–Vietnam Airlines has signed a Memorandum of Understanding (MOU) with global technology corporation FPT to strengthen comprehensive... Read more.
New Two-year Follow-up of Genentech’s Columvi Extends Overall Survival in Relapsed or Refractory Diffuse Large B-cell Lymphoma Patients
– Updated data from the pivotal Phase III STARGLO study continue to demonstrate a clinically meaningful improvement in overall survival with a 40% survival benefit... Read more.
Curatis discloses Corticorelin as active substance of C-PTBE-01
Corticorelin Market Opportunity in Peritumoral Brain Edema (PTBE) expected to exceed USD 1 billion; Strengthens team with Dr. Kirsty Crame and Dr. Timm Trenktrog... Read more.
Outcome of Innate Pharma’s 2025 Annual General Meeting
MARSEILLE, France–(BUSINESS WIRE)–#AG–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”)... Read more.
Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides
Long term follow-up data from the TELLOMAK Phase 2 trial in Sézary syndrome (SS) and mycosis fungoides (MF) will be presented at the ASCO Annual Meeting 2025. Long-term... Read more.
Guardian Pharmacy Services Announces Pricing of Underwritten Public Offering of Class A Common Stock
ATLANTA–(BUSINESS WIRE)–Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the pricing of the previously announced underwritten... Read more.